Literature DB >> 28189747

An integrated CRISPR Bombyx mori genome editing system with improved efficiency and expanded target sites.

Sanyuan Ma1, Yue Liu2, Yuanyuan Liu2, Jiasong Chang2, Tong Zhang2, Xiaogang Wang2, Run Shi2, Wei Lu2, Xiaojuan Xia2, Ping Zhao1, Qingyou Xia3.   

Abstract

Genome editing enabled unprecedented new opportunities for targeted genomic engineering of a wide variety of organisms ranging from microbes, plants, animals and even human embryos. The serial establishing and rapid applications of genome editing tools significantly accelerated Bombyx mori (B. mori) research during the past years. However, the only CRISPR system in B. mori was the commonly used SpCas9, which only recognize target sites containing NGG PAM sequence. In the present study, we first improve the efficiency of our previous established SpCas9 system by 3.5 folds. The improved high efficiency was also observed at several loci in both BmNs cells and B. mori embryos. Then to expand the target sites, we showed that two newly discovered CRISPR system, SaCas9 and AsCpf1, could also induce highly efficient site-specific genome editing in BmNs cells, and constructed an integrated CRISPR system. Genome-wide analysis of targetable sites was further conducted and showed that the integrated system cover 69,144,399 sites in B. mori genome, and one site could be found in every 6.5 bp. The efficiency and resolution of this CRISPR platform will probably accelerate both fundamental researches and applicable studies in B. mori, and perhaps other insects.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bombyx mori; Cas9; Cpf1; Editing efficiency; Genome editing; Target site

Mesh:

Year:  2017        PMID: 28189747     DOI: 10.1016/j.ibmb.2017.02.003

Source DB:  PubMed          Journal:  Insect Biochem Mol Biol        ISSN: 0965-1748            Impact factor:   4.714


  7 in total

1.  A Survey of Genome Editing Activity for 16 Cas12a Orthologs.

Authors:  Bernd Zetsche; Omar O Abudayyeh; Jonathan S Gootenberg; David A Scott; Feng Zhang
Journal:  Keio J Med       Date:  2019-11-14

2.  Transgenic Silkworm-Based Silk Gland Bioreactor for Large Scale Production of Bioactive Human Platelet-Derived Growth Factor (PDGF-BB) in Silk Cocoons.

Authors:  Wenjing Chen; Feng Wang; Chi Tian; Yuancheng Wang; Sheng Xu; Riyuan Wang; Kai Hou; Ping Zhao; Ling Yu; Zhisong Lu; Qingyou Xia
Journal:  Int J Mol Sci       Date:  2018-08-27       Impact factor: 5.923

3.  Mb- and FnCpf1 nucleases are active in mammalian cells: activities and PAM preferences of four wild-type Cpf1 nucleases and of their altered PAM specificity variants.

Authors:  Eszter Tóth; Bernadett C Czene; Péter I Kulcsár; Sarah L Krausz; András Tálas; Antal Nyeste; Éva Varga; Krisztina Huszár; Nóra Weinhardt; Zoltán Ligeti; Adrienn É Borsy; Elfrieda Fodor; Ervin Welker
Journal:  Nucleic Acids Res       Date:  2018-11-02       Impact factor: 16.971

4.  Genome-wide CRISPR screening reveals genes essential for cell viability and resistance to abiotic and biotic stresses in Bombyx mori.

Authors:  Jiasong Chang; Ruolin Wang; Kai Yu; Tong Zhang; Xiaoxu Chen; Yue Liu; Run Shi; Xiaogang Wang; Qingyou Xia; Sanyuan Ma
Journal:  Genome Res       Date:  2020-05-18       Impact factor: 9.043

5.  Melanin Synthesis Pathway Interruption: CRISPR/Cas9-mediated Knockout of dopa decarboxylase (DDC) in Harmonia axyridis (Coleoptera: Coccinellidae).

Authors:  Meng-Meng Wu; Xu Chen; Qing-Xuan Xu; Lian-Sheng Zang; Su Wang; Ming Li; Da Xiao
Journal:  J Insect Sci       Date:  2022-09-01       Impact factor: 2.066

6.  Programmable Single and Multiplex Base-Editing in Bombyx mori Using RNA-Guided Cytidine Deaminases.

Authors:  Yufeng Li; Sanyuan Ma; Le Sun; Tong Zhang; Jiasong Chang; Wei Lu; Xiaoxu Chen; Yue Liu; Xiaogang Wang; Run Shi; Ping Zhao; Qingyou Xia
Journal:  G3 (Bethesda)       Date:  2018-05-04       Impact factor: 3.154

Review 7.  Class 2 CRISPR/Cas: an expanding biotechnology toolbox for and beyond genome editing.

Authors:  Yuyi Tang; Yan Fu
Journal:  Cell Biosci       Date:  2018-11-12       Impact factor: 7.133

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.